Cahen, Djuna L.

Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium

Goggins, M., Overbeek, K. A., Brand, R., Syngal, S., Del Chiaro, M., Bartsch, D. K., Bassi, C., Carrato, A., Farrell, J., Fishman, E. K., et al. (2020) · Gut

Pancreatic and Hepatic Oncology ResearchPancreatitis Pathology and Treatment

Cited by 659

European experts consensus statement on cystic tumours of the pancreas

Del Chiaro, M., Verbeke, C., Salvia, R., Klöppel, G., Werner, J., McKay, C., Friess, H., Manfredi, R., Van Cutsem, E., Löhr, M., et al. (2013) · Digestive and Liver Disease

Pancreatic and Hepatic Oncology ResearchPancreatitis Pathology and Treatment

Cited by 498

Long-term yield of pancreatic cancer surveillance in high-risk individuals

Overbeek, K. A., Levink, I. J. M., Koopmann, B. D. M., Harinck, F., Konings, I. C. A. W., Ausems, M. G. E. M., Wagner, A., Fockens, P., van Eijck, C. H., Groot Koerkamp, B., et al. (2022) · Gut

Pancreatic and Hepatic Oncology ResearchGenetic factors in colorectal cancer

Cited by 164

Twelve week liraglutide or sitagliptin does not affect hepatic fat in type 2 diabetes: a randomised placebo-controlled trial

Smits, M. M., Tonneijck, L., Muskiet, M. H. A., Kramer, M. H. H., Pouwels, P. J. W., Pieters-van den Bos, I. C., Hoekstra, T., Diamant, M., van Raalte, D. H., & Cahen, D. L. (2016) · Diabetologia

Diabetes Treatment and ManagementLiver Disease Diagnosis and Treatment

Cited by 142

Timeline of Development of Pancreatic Cancer and Implications for Successful Early Detection in High-Risk Individuals

Overbeek, K. A., Goggins, M. G., Dbouk, M., Levink, I. J. M., Koopmann, B. D. M., Chuidian, M., Konings, I. C. A. W., Paiella, S., Earl, J., Fockens, P., et al. (2022) · Gastroenterology

Pancreatic and Hepatic Oncology ResearchGlobal Cancer Incidence and Screening

Cited by 114

Gastrointestinal actions of glucagon‐like peptide‐1‐based therapies: glycaemic control beyond the pancreas

Smits, M. M., Tonneijck, L., Muskiet, M. H. A., Kramer, M. H. H., Cahen, D. L., & van Raalte, D. H. (2016) · Diabetes, Obesity and Metabolism

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 74

Biliary effects of liraglutide and sitagliptin, a 12‐week randomized placebo‐controlled trial in type 2 diabetes patients

Smits, M. M., Tonneijck, L., Muskiet, M. H. A., Hoekstra, T., Kramer, M. H. H., Diamant, M., Nieuwdorp, M., Groen, A. K., Cahen, D. L., & van Raalte, D. H. (2016) · Diabetes, Obesity and Metabolism

Diabetes Treatment and ManagementGallbladder and Bile Duct Disorders

Cited by 56

Surveillance for neoplasia in the pancreas

Overbeek, K. A., Cahen, D. L., Canto, M. I., & Bruno, M. J. (2016) · Best Practice & Research Clinical Gastroenterology

Pancreatic and Hepatic Oncology ResearchPancreatitis Pathology and Treatment

Cited by 28

Pancreatic Effects of Liraglutide or Sitagliptin in Overweight Patients With Type 2 Diabetes: A 12-Week Randomized, Placebo-Controlled Trial

Smits, M. M., Tonneijck, L., Muskiet, M. H. A., Kramer, M. H. H., Pieters-van den Bos, I. C., Vendrik, K. E. W., Hoekstra, T., Bruno, M. J., Diamant, M., van Raalte, D. H., et al. (2017) · Diabetes Care

Diabetes Treatment and ManagementPancreatitis Pathology and Treatment

Cited by 23

Acute plasma amylase increase after glucagon‐like peptide ‐1 receptor agonist exenatide administration in Type 2 diabetes

Smits, M. M., Tonneijck, L., Muskiet, M. H. A., Diamant, M., Kramer, M. H. H., Cahen, D. L., & van Raalte, D. H. (2017) · Diabetic Medicine

Diabetes Treatment and ManagementPancreatitis Pathology and Treatment

Cited by 7